share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Upadhyay Suketu

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Upadhyay Suketu

福泰制药 | 4：持股变动声明-董事 Upadhyay Suketu
美股sec公告 ·  05/03 16:31
Moomoo AI 已提取核心信息
On May 1, 2024, Suketu Upadhyay, engaged in transactions involving Vertex Pharmaceuticals Inc. (VRTX) common stock. Upadhyay acquired 1,001 shares at no cost, which was reported as a grant, award, or other acquisition. On the same day, Upadhyay disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, Upadhyay's direct holdings in Vertex Pharmaceuticals amounted to 2,559 shares. The transactions have been marked as completed.
On May 1, 2024, Suketu Upadhyay, engaged in transactions involving Vertex Pharmaceuticals Inc. (VRTX) common stock. Upadhyay acquired 1,001 shares at no cost, which was reported as a grant, award, or other acquisition. On the same day, Upadhyay disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, Upadhyay's direct holdings in Vertex Pharmaceuticals amounted to 2,559 shares. The transactions have been marked as completed.
2024年5月1日，Suketu Upadhyay参与了涉及Vertex Pharmicals Inc.（VRTX）普通股的交易。Upadhyay免费收购了1,001股股票，这被报告为赠款、奖励或其他收购。同一天，Upadhyay出售了1,168股股票；但是，交易价格没有披露。这些交易之后，Upadhyay在Vertex Pharmicals的直接持股量为2559股。交易已标记为已完成。
2024年5月1日，Suketu Upadhyay参与了涉及Vertex Pharmicals Inc.（VRTX）普通股的交易。Upadhyay免费收购了1,001股股票，这被报告为赠款、奖励或其他收购。同一天，Upadhyay出售了1,168股股票；但是，交易价格没有披露。这些交易之后，Upadhyay在Vertex Pharmicals的直接持股量为2559股。交易已标记为已完成。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息